Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.85USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,789
52-wk High
$3.82
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
FY 2016 Dec '16 0.00 -0.003
Sep '16 -0.001
Jun '16 0.00 -0.002
Mar '16 -0.002
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. 329.55 292.71 45.97
P/E Low - Last 5 Yrs. 329.55 91.44 24.37
Beta -0.08 0.90 0.89
Price to Sales (TTM) -- 110.72 5.77
Price to Book (MRQ) 0.67 13.56 5.41
Price to Tangible Book (MRQ) 6.40 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 1.12 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.50 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago 21.36 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 40.63 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 17.78 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -- -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -- -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -- -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,602,130 855,673,508
Net Income/Employee (TTM) -- 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.00 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.01 -1.05 10.98
Return on Assets - 5 Yr. Avg. -30.54 -0.57 12.37
Return on Investment (TTM) -70.95 1.66 14.43
Return on Investment - 5 Yr. Avg. -39.11 2.23 16.18
Return on Equity (TTM) -125.01 2.58 16.13
Return on Equity - 5 Yr. Avg. -32.85 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 32.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.41%
# of Holders: 5
Total Shares Held: 226,757
3 Mo. Net Change: 121,045
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.